Showing results (31-40 of 497) with videos related to

Sort By:
Pageof 50
Breast Cancer (Tokyo, Japan)|June 7, 2006
Who benefits from hormone therapy?Masakazu Toi, Yuichi Iino
Expert Opinion on Pharmacotherapy|March 10, 2018
Abemaciclib for the treatment of breast cancerTakeshi Kotake, Masakazu Toi
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Molecular targeted therapy and genomic evolution of breast cancer]Fumiaki Sato, Masakazu Toi
World Journal of Clinical Cases|December 22, 2023
Abemaciclib-induced lung damage leading to discontinuation in brain metastases from breast cancer: A case reportHiroyasu Yamashiro, Nao Morii
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2003
Anti-angiogenic therapy in breast cancerMohammad Atiqur Rahman, Masakazu Toi
Breast Cancer (Tokyo, Japan)|November 20, 2004
Novel sensitizing agents: potential contribution of COX-2 inhibitor for endocrine therapy of breast cancerShigehira Saji, Makiko Hirose, Masakazu Toi
Medical Oncology (Northwood, London, England)|September 29, 2022
Tumor immune microenvironment and systemic response in breast cancerKosuke Kawaguchi, Yurina Maeshima, Masakazu Toi
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 23, 2003
Decision tree and paradigms of primary breast cancer: changes elicited by preoperative therapyMasakazu Toi, Hiroko Bando, Shigehira Saji
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 11, 2013
Comparison of robustness against missing values of alternative decision tree and multiple logistic regression for predicting clinical data in primary breast cancerMasahiro Sugimoto, Masahiro Takada, Masakazu Toi
Pageof 50